Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Papathanassiou (Athens , Greece), A. Papaioannou (Athens , Greece), G. Hillas (Athens , Greece), E. Mizi (Athens , Greece), P. Bakakos (Athens , Greece), V. Apollonatou (Athens , Greece), G. Verykokou (Athens , Greece), N. Roussakis (Athens , Greece), Z. Tsilogianni (Athens , Greece), K. Kostikas (Athens , Greece), S. Papiris (Athens , Greece), S. Loukides (Athens , Greece). Eosinophils and acute exacerbation of COPD: a potent biomarker for patients at increased risk. Preliminary reports.. 2016

Member's Comments

No comment yet.

Related content which might interest you: Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021 Is anemia associated with readmission risk in severe acute exacerbation of COPD: Preliminary results from a naturalistic cohort Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005 Longitudinal measurement of airway inflammation relates to a higher risk of exacerbation in COPD. Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies. Source: International Congress 2017 – Pulmonary embolism Year: 2017 Aspirin inhalation treatment for COPD patients: Preliminary studies on PK and inflammatory biomarkers Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Glycated hemoglobin (HbA1c) and acute exacerbation in chronic obstructive pulmonary disease: a potent biomarker of severity and prognosis. Preliminary data. Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021